Short Interest in CSL Limited (OTCMKTS:CSLLY) Decreases By 72.0%

CSL Limited (OTCMKTS:CSLLY - Get Free Report) saw a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 6,300 shares, a decline of 72.0% from the January 15th total of 22,500 shares. Based on an average daily volume of 163,300 shares, the short-interest ratio is presently 0.0 days.

CSL Stock Performance

OTCMKTS CSLLY traded up $0.05 on Friday, hitting $80.77. 156,773 shares of the company's stock traded hands, compared to its average volume of 85,205. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18. CSL has a 1-year low of $77.37 and a 1-year high of $109.00. The firm's 50-day moving average price is $86.60 and its two-hundred day moving average price is $93.93.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group raised shares of CSL to a "strong-buy" rating in a research report on Thursday, January 16th.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.